The Genotype and Phenotype of Lymphangioleiomyomatosis

Recruiting Observational Study
Sporadic Lymphangioleiomyomatosis TSC-associated Lymphangioleiomyomatosis
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
National Taiwan University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to differentiate between sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex-associated Lymphangioleiomyomatosis.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * age ≥ 18 y/o * Patient with Chest CT showed cystic lung disease, suspected Lymphangioleiomyomatosis Exclusion Criteria: * age \< 18 y/o
Contacts

Yao-Wen Kuo

0972-651-821

kyw@ntu.edu.tw

CONTACT